share_log

Burcon Announces Virtual AGM Details

Burcon Announces Virtual AGM Details

Burcon 宣佈虛擬股東周年大會詳情
newsfile ·  2023/08/28 20:00

Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company") a global technology leader in the development of plant-based proteins for foods and beverages, today announced details for its upcoming virtual Annual General and Special Meeting (the "AGM") to be held on Wednesday, September 20, 2023 at 10:00 am Pacific Time.

溫哥華,不列顛哥倫比亞省-(Newsfile Corp.-2023年8月28日)-Burcon NutraScience Corporation(多倫多證券交易所股票代碼:BU)(“Burcon”或“公司”)是食品和飲料用植物蛋白開發領域的全球技術領先企業,該公司今天宣佈了即將於2023年9月20日(星期三)太平洋時間上午10:00舉行的虛擬年度股東大會(“AGM”)的細節。

To Attend the AGM Webcast

參加年度股東大會網路直播

Shareholders and duly appointed proxyholders can attend the AGM and view the Company's presentation at:

股東和正式指定的代表持有人可出席年度股東大會,並可在以下網址觀看公司的演示文稿:

To Vote at the AGM

在年度股東大會上投票

Burcon's Notice of Meeting, Management Information Circular (the "Circular") and the Form of Proxy (collectively the "Meeting Materials") were mailed on or about August 14, 2023. For shareholders who have not yet received the Meeting Materials, please contact your broker if you are a non-registered shareholder or contact Computershare if you are a registered shareholder.

博康的會議通知、管理資訊通告(“通函”)和委託書表格(統稱為“會議材料”)於2023年8月14日左右郵寄。對於尚未收到會議材料的股東,如果您是非註冊股東,請與您的經紀人聯繫;如果您是註冊股東,請與ComputerShare聯繫。

Attending and voting at the AGM will only be available for registered shareholders and duly appointed proxyholders. Non-registered shareholders may login as a guest, however, they will not be able to vote.

只有登記股東和正式委任的代表持有人才能出席年度股東大會並投票。非註冊股東可以作為客人登錄,但他們將無法投票。

In order to streamline the virtual meeting process, the Company is encouraging all shareholders to vote in advance of the meeting using the Voting Instruction Form or the Form of Proxy mailed with the Meeting Materials and to do so by 10:00 am Pacific Time on September 18, 2023.

為了簡化虛擬會議流程,公司鼓勵所有股東在會議前使用投票指示表格或與會議材料一起郵寄的代理表格進行投票,並在太平洋時間2023年9月18日上午10點之前投票。

To Submit Questions for the AGM

向年度股東大會提交問題

Shareholders wishing to have a question addressed at the AGM can submit them in advance to plam@burcon.ca. The Company will address these questions as part of the presentation by CEO Kip Underwood.

希望在年度股東大會上提出問題的股東可以提前將問題提交到plam@burcon.ca。該公司將在首席執行官基普·安德伍德的演講中回答這些問題。

About Burcon NutraScience Corporation

關於Burcon NutraScience公司

Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is striving to become a vertically integrated provider of specialty plant-based protein solutions that deliver on health, nutrition and sustainability. Supporting the growing trend towards a plant-based diet, Burcon is developing premium protein ingredients that we believe are better for you and better for the planet. For more information, visit burcon.ca.

Burcon是食品和飲料用植物蛋白開發領域的全球技術領先者。我們的蛋白質表現出卓越的功能性、口感和營養,使其成為食品配方設計師的理想配料。憑藉二十多年的經驗,Burcon積累了廣泛的專利組合,涵蓋其從豌豆、油菜籽、大豆、大麻和葵花籽等植物來源提取的特種植物蛋白。博康致力於成為一家垂直整合的特色植物蛋白解決方案供應商,提供健康、營養和可持續發展。為了支持日益增長的植物性飲食趨勢,博康正在開發優質蛋白質成分,我們相信這些成分對你和地球都更好。欲瞭解更多資訊,請訪問burcon.ca。

Forward-Looking Information Cautionary Statement

前瞻性資訊警示聲明

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2023 and its other public filings with Canadian securities regulators on SEDAR at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

多倫多證券交易所沒有對本文所含資訊內容的充分性進行審查,也不承擔任何責任。本新聞稿包含符合1995年美國私人證券訴訟改革法和適用的加拿大證券法的前瞻性陳述或前瞻性資訊。前瞻性陳述或前瞻性資訊涉及風險、不確定因素和其他因素,可能導致實際結果、業績、前景和機會與此類前瞻性陳述明示或暗示的內容大不相同。前瞻性陳述或前瞻性資訊可以用諸如“預期”、“目標”、“打算”、“計劃”、“目標”、“專案”、“估計”、“預期”、“相信”、“未來”、“可能”、“可能”、“應該”、“可能”、“將”等詞語以及對未來時期的類似提法來識別。除有關歷史事實的陳述外,本新聞稿中包含的所有陳述均為前瞻性陳述。不能保證這些陳述將被證明是準確的,實際結果和未來事件可能與這些陳述或資訊中預期的大不相同。可能導致實際結果與Burcon的計劃和預期大不相同的重要因素包括:我們業務模式和增長戰略的實施;我們行業的趨勢和競爭;我們未來的業務發展、財務狀況和經營結果以及我們以高成本效益獲得融資的能力;政府法規的潛在變化;以及Burcon在本文和Burcon不時提交給證券監管機構和證券交易所的檔案中列出的其他風險和因素,包括Burcon提交給加拿大證券監管機構的截至2023年3月31日的年度資訊表格中題為“風險因素”的章節,以及它提交給加拿大證券監管機構的其他公開檔案中的SEDAR at。這份清單並沒有詳盡列出可能影響公司任何前瞻性陳述或資訊的因素。任何前瞻性聲明或資訊僅在作出之日發表,除非適用的證券法可能要求,否則博康公司不會因為新資訊、未來事件或其他原因而更新任何前瞻性聲明,也不承擔任何義務。儘管Burcon認為前瞻性陳述中固有的假設是合理的,但前瞻性陳述並不能保證未來的業績,因此,投資者不應依賴此類陳述。

Industry and Investor Contact

行業和投資者聯繫方式

Paul Lam
Director, Investor Relations
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca

林偉強
董事,投資者關係
博康營養科學公司
電話(604)733-0896,免費電話(888)408-7960
郵箱:plam@burcon.ca

Media Contact:

媒體聯繫人:

Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

史蒂夫·坎貝爾,APR
總裁
坎貝爾與公司公共關係
電話:(604)888-5267
郵箱:tech@ccom-pr.com

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論